Trial Profile
A Phase 1/2a Study of LON002 (Sublingual Artemether Spray) in Subjects With Advanced Solid Tumours.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Artemether (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors LondonPharma
- 21 Nov 2014 New trial record